HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pulmonary thromboembolism after surgery for esophageal cancer: its features and prophylaxis.

Abstract
We attempt to clarify the problems of pulmonary thromboembolism (PTE), which occurs less frequently in Japan than in the West, regarding its special perioperative management and prophylaxis for PTE after esophagectomy. We studied 26 patients with PTE following esophagectomy among 1023 patients with esophageal cancer between 1984 and 1997. The presence of embolism was confirmed by pulmonary perfusion scintigraphy. The incidence, diagnosis, and other issues of PTE were all reviewed. The incidence of PTE was 2.5%, with patients showing a biphasic early and late onset. The main symptoms were dyspnea in 19 patients and tachycardia in 17. Scintigraphy demonstrated 154 lesions, 35.7% of which were located in the left lower lobe and 25.3% in the right lower lobe. Treatment mainly consisted of the administration of heparin and urokinase. Four of the 26 patients died. Intermittent pneumatic compression (IPC) with the administration of heparin has been used in our department since 1994 to prevent PTE and this has also helped to decrease the incidence from 3.2% to 0.7%. Because the incidence of PTE following esophagectomy is higher than expected, PTE should be considered whenever hypoxemia of some unknown cause is found. Both early diagnosis and treatment are essential. It is also important to prevent PTE by the use of IPC.
AuthorsK Tsutsumi, H Udagawa, Y Kajiyama, Y Kinoshita, M Ueno, T Nakamura, M Tsurumaru, H Akiyama
JournalSurgery today (Surg Today) Vol. 30 Issue 5 Pg. 416-20 ( 2000) ISSN: 0941-1291 [Print] Japan
PMID10819476 (Publication Type: Journal Article)
Topics
  • Esophageal Neoplasms (diagnosis, surgery)
  • Esophagectomy (adverse effects, methods)
  • Female
  • Humans
  • Incidence
  • Japan (epidemiology)
  • Male
  • Postoperative Complications (prevention & control)
  • Preoperative Care
  • Prognosis
  • Pulmonary Embolism (diagnostic imaging, epidemiology, etiology)
  • Radionuclide Imaging
  • Retrospective Studies
  • Risk Factors
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: